{"result": "(\"entity\"<|>MASAS SUPRARRENALES<|>EVENT<|>Masas suprarrenales refer to adrenal masses that can be indicative of tumors such as feochromocytomas or paragangliomas, often detected through imaging techniques like TAC.)\n##\n(\"entity\"<|>HIPERSECRECIÓN DE CATECOLAMINAS<|>EVENT<|>Hipersecreción de catecolaminas refers to the excessive secretion of catecholamines, which is a common symptom associated with feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>TAC ABDOMINAL<|>EVENT<|>TAC abdominal is a specific type of CT scan used to visualize abdominal organs, including the detection of adrenal masses related to feochromocytomas.)\n##\n(\"entity\"<|>PRUEBAS COMPLEMENTARIAS DE IMAGEN<|>EVENT<|>Pruebas complementarias de imagen refer to additional imaging tests that may be conducted to further investigate the presence of tumors like feochromocytomas or paragangliomas.)\n##\n(\"entity\"<|>GAMMAGRAFÍA CON MIBG<|>EVENT<|>Gammagrafía con MIBG is a specific imaging test used to detect feochromocytomas and paragangliomas by highlighting areas of catecholamine production.)\n##\n(\"entity\"<|>OCTREOSCAN<|>EVENT<|>Octreoscan is a functional imaging test used to visualize neuroendocrine tumors, including feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>MUTACIONES EN LÍNEA GERMINAL<|>EVENT<|>Mutaciones en línea germinal refer to hereditary mutations that can increase the risk of developing tumors such as feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>TUMORES<|>EVENT<|>Tumores refer to abnormal growths of tissue that can be benign or malignant, including feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>HORMONAS<|>EVENT<|>Hormonas refer to chemical messengers in the body, such as catecholamines, which can be affected by tumors like feochromocytomas.)\n##\n(\"entity\"<|>CATECOLAMINAS Y METANEFRINAS<|>EVENT<|>Catecolaminas y metanefrinas are metabolites of catecholamines that are often measured in the laboratory to diagnose conditions like feochromocytomas.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: lo que es poco probable que el tumor esté localizado en el cuello.\n     na con feocromocitomas suprarrenales que presentan un fenotipo bioquímico suprarrenal.                                                              C. El perfil bioquímico orienta posiblemente a un MEN2.\n     El primer grupo incluye mutaciones germinales en SDHD, SDHC, SDHB, SDHAF2, SDHA, VHL,                                                               D.  La mayoría de los feocromocitomas/paragangliomas se localizan en el abdomen.\n     HIF2, FH gen codificante de fumarato hidratasa, EGLN1 (PHD2), EGLN2 (PHD1) y KIFB. El\n     segundo grupo incluye mutaciones germinales en los genes RET, NF1, MAX y TMEM127.                                                            56     Se realiza TAC abdominal con los siguientes hallazgos: masas suprarrenales\n     La hipersecreción de catecolaminas asociada a paragangliomas dependerá de la locali-                                                                bilaterales que presentan marcado realce tras la administración de contraste\n     zación de los mismos, de manera que solo son hipersecretores el 5% de los localizados en                                                            intravenoso. A descartar feocromocitoma como primera posibilidad (lado izquierdo\n     la base del cráneo y cuello, pero serán hipersecretores de catecolaminas más del 50% de                                                             2,4 × 3,3 cm y lado derecho 4,8 × 3,7 cm). Respecto a las pruebas complementarias\n     los localizados en el abdomen.                                                                                                                      de imagen, señale la opción correcta:\n     El orden sugerido de estudio genético en caso de detectar un paraganglioma abdominal                                                                A. Las indicaciones para realizar una gammagrafía con metayodobencilguanidina (MIBG)\n     sería SDHB, SDHD, VHL y SDHC.                                                                                                                           corporal total en pacientes diagnosticados de feocromocitoma son: tumor suprarrenal\n     La inmunohistoquímica para               SDHB de la pieza histológica puede servir para descartar                                                       de más de 5 cm o existencia de un paraganglioma extraadrenal.\n     mutaciones en SDHB, SDHC y SDHD, ya que, en caso de mutaciones en línea germinal, los                                                               B. El hallazgo de una lesión suprarrenal de 3 cm en TAC con densidad inferior a 10 unidades\n     tumores presentan una tinción ausente o en patrón difuso débil. Por lo tanto, en caso de                                                                Hounsfield, homogénea, es sugestivo de malignidad.\n     ausencia de tinción será necesario el estudio genético, comenzando con SDHB.                                                                        C. En pacientes con diagnóstico de paraganglioma maligno, la sensibilidad de la 18F-FDG\n     Una vez confirmado el exceso de producción de catecolaminas con los test bioquímicos se de-                                                             es superior a la de gammagrafía con MIBG para la detección de enfermedad metastásica.\n     ben realizar las pruebas de imagen para la localización del tumor. Habitualmente, la primera                                                        D.  El octreoscan es la prueba de imagen funcional de elección en el estudio de pacientes\n     prueba de imagen solicitada suele ser una TAC con contraste por su excelente resolución espa-                                                           con feocromocitoma/paraganglioma.\n     cial, con una sensibilidad entre el 88% y 100% y que permite detectar tumores de hasta 5 mm.\n     Debe recordarse que los pacientes con mutaciones en                         SDHB     presentan más a menudo                                  57     Todas las sustancias indicadas pueden dar lugar a falsos positivos por elevación\n     paragangliomas en tórax y abdomen, y en un 50% de los casos presentan metástasis                                                                    de los niveles de catecolaminas y metanefrinas medidos en el laboratorio, excepto:\n     a distancia. Otras patologías que pueden asociarse en caso de mutaciones en SDHB son\n     cáncer renal, cáncer de tiroides y tumores del estroma gastrointestinal (GIST).                                                                     A. Atorvastatina.\n     Referencias:                                                                                                                                        B. Antidepresivos tricíclicos.\n     • Díaz Pérez JA, Crespo Hernández I. Feocromocitoma y paraganglioma. Manual de Endocrinología y Nutrición. Disponible en: https://manual.           C. Anfetaminas.\n       seen.es (última modificación: 24 de noviembre de 2015).\n     • Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma:                           D.  Cocaína.\n       an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99:1915-41.\n     • Neumann HPH. Feocromocitoma\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>FEOCROMOCITOMA<|>EVENT<|>Feocromocitoma is a type of tumor that arises from chromaffin cells and can lead to the hypersecretion of catecholamines, affecting various bodily functions.)\n##\n(\"entity\"<|>PARAGANGLIOMA<|>EVENT<|>Paraganglioma is a tumor that arises from paraganglia, which are clusters of nerve cells, and can also lead to catecholamine secretion.)\n##\n(\"entity\"<|>SDHB<|>PERSON<|>SDHB is a gene associated with hereditary paraganglioma and feochromocytoma syndromes, and its mutations can lead to the development of these tumors.)\n##\n(\"entity\"<|>SDHD<|>PERSON<|>SDHD is a gene that, when mutated, is linked to hereditary paraganglioma and feochromocytoma syndromes.)\n##\n(\"entity\"<|>VHL<|>PERSON<|>VHL is a gene that is associated with von Hippel-Lindau syndrome, which can include the development of feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>NF1<|>PERSON<|>NF1 is a gene associated with neurofibromatosis type 1, which can increase the risk of developing feochromocytomas.)\n##\n(\"entity\"<|>MAX<|>PERSON<|>MAX is a gene that, when mutated, can be associated with hereditary syndromes that include the risk of developing feochromocytomas.)\n##\n(\"entity\"<|>TMEM127<|>PERSON<|>TMEM127 is a gene linked to hereditary paraganglioma and feochromocytoma syndromes.)\n##\n(\"entity\"<|>TAC<|>EVENT<|>TAC (Tomografía Axial Computarizada) is an imaging technique used to detect tumors, including feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>CATECOLAMINAS<|>EVENT<|>Catecolaminas are hormones produced by the adrenal glands that can be excessively secreted in cases of feochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>CANCER RENAL<|>EVENT<|>Cancer renal refers to kidney cancer, which can be associated with mutations in genes like SDHB.)\n##\n(\"entity\"<|>CANCER DE TIROIDES<|>EVENT<|>Cancer de tiroides refers to thyroid cancer, which can also be associated with mutations in genes like SDHB.)\n##\n(\"entity\"<|>TUMORES DEL ESTROMA GASTROINTESTINAL<|>EVENT<|>Tumores del estroma gastrointestinal (GIST) are tumors that can occur in the gastrointestinal tract and are associated with certain genetic mutations.)\n##\n(\"relationship\"<|>FEOCROMOCITOMA<|>PARAGANGLIOMA<|>Feocromocitoma and paraganglioma are both types of tumors that can arise from chromaffin cells and paraganglia, respectively, and can lead to similar symptoms due to catecholamine secretion.<|>8)\n##\n(\"relationship\"<|>SDHB<|>FEOCROMOCITOMA<|>Mutations in the SDHB gene are linked to the development of feochromocytomas, making it a significant factor in hereditary cases.<|>9)\n##\n(\"relationship\"<|>SDHB<|>PARAGANGLIOMA<|>Mutations in the SDHB gene are also associated with the development of paragangliomas, indicating a genetic link.<|>9)\n##\n(\"relationship\"<|>SDHD<|>FEOCROMOCITOMA<|>Mutations in the SDHD gene can lead to an increased risk of developing feochromocytomas, indicating a hereditary connection.<|>7)\n##\n(\"relationship\"<|>SDHD<|>PARAGANGLIOMA<|>Mutations in the SDHD gene are also associated with paragangliomas, showing a genetic predisposition.<|>7)\n##\n(\"relationship\"<|>VHL<|>FEOCROMOCITOMA<|>The VHL gene is associated with von Hippel-Lindau syndrome, which can include feochromocytomas among its manifestations.<|>6)\n##\n(\"relationship\"<|>VHL<|>PARAGANGLIOMA<|>The VHL gene is also linked to the development of paragangliomas in patients with von Hippel-Lindau syndrome.<|>6)\n##\n(\"relationship\"<|>NF1<|>FEOCROMOCITOMA<|>The NF1 gene is associated with neurofibromatosis type 1, which can increase the risk of developing feochromocytomas.<|>5)\n##\n(\"relationship\"<|>MAX<|>FEOCROMOCITOMA<|>Mutations in the MAX gene can be linked to hereditary syndromes that include feochromocytomas, indicating a genetic risk.<|>5)\n##\n(\"relationship\"<|>TMEM127<|>FEOCROMOCITOMA<|>The TMEM127 gene is associated with hereditary paraganglioma and feochromocytoma syndromes, indicating a genetic link.<|>5)\n##\n(\"relationship\"<|>TAC<|>FEOCROMOCITOMA<|>TAC is commonly used as an imaging technique to detect feochromocytomas, making it a relevant diagnostic tool.<|>8)\n##\n(\"relationship\"<|>CATECOLAMINAS<|>FEOCROMOCITOMA<|>Catecolaminas are hormones that are often excessively secreted in cases of feochromocytomas, linking them directly.<|>9)\n##\n(\"relationship\"<|>CANCER RENAL<|>SDHB<|>Mutations in the SDHB gene can lead to an increased risk of developing renal cancer, indicating a genetic connection.<|>6)\n##\n(\"relationship\"<|>CANCER DE TIROIDES<|>SDHB<|>The SDHB gene is also associated with an increased risk of thyroid cancer, showing a hereditary link.<|>6)\n##\n(\"relationship\"<|>TUMORES DEL ESTROMA GASTROINTESTINAL<|>SDHB<|>Mutations in the SDHB gene can lead to gastrointestinal stromal tumors, indicating a genetic predisposition.<|>6)\n<|COMPLETE|>"}]}